Matthew Rabinowitz

Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution

Matthew Rabinowitz, Roelof Botha, Jonathan Sheena, Steve Chapman, Chitra Kotwaliwale, Sarah Elliot, Rolof Buerta

Co-founded by Matthew Rabinovitz and Jonathan Sheena, Natera has evolved from a specialized IVF testing provider into a global leader in genetic diagnostics, now processing 40% of U.S. pregnancies and capturing nearly half of oncologists' orders for its Signatera cancer monitoring test. The company successfully navigated significant financial volatility and strategic pivots to achieve a $1.5 billion revenue forecast, with its stock appreciating from $7 to over $100 per share following the clinical validation and market adoption of its oncology division. Today, Natera maintains a dominant market position in women's health genetics and minimal residual disease monitoring while leveraging AI to further expand its early detection capabilities across solid tumors.